UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 861177 NEW YORK, NY

Back to PRAX Full portfolio

Position in PRAX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$12,289,934

+$1,889,153 QoQ

Shares Held

38,145

+8.1% QoQ

Ownership

0.137%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 40.04718836020448.ToString("F0")% Shared 0.ToString("F0")% None 59.95281163979552.ToString("F0")%

Common Shares in PRAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. PRAX ranks #37 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,057,396	$1,365,249,602
2	REGN	Regeneron Pharmaceuticals, Inc.	723,621	$559,098,523
3	ALNY	Alnylam Pharmaceuticals, Inc.	677,519	$224,170,706
4	INSM	INSMED Inc	1,215,025	$198,680,883
5	RPRX	Royalty Pharma plc	3,095,766	$148,503,890
6	INCY	Incyte Corp	1,540,913	$145,030,725
7	IONS	Ionis Pharmaceuticals Inc	1,475,632	$110,805,201
8	DNLI	Denali Therapeutics Inc.	4,432,314	$85,100,425

All Filings in PRAX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,289,934	38,145	+8.1%	Shares	Defined	2026-05-13
2025-12-31	$10,400,781	35,288	+48.5%	Shares	Defined	2026-02-13
2025-09-30	$1,259,068	23,756	-75.5%	Shares	Defined	2025-11-14
2025-06-30	$4,076,536	96,945	+11.3%	Shares	Defined	2025-08-14
2025-03-31	$3,297,757	87,081	+367.8%	Shares	Defined	2025-05-19
2024-12-31	$1,432,610	18,615	+17.3%	Shares	Defined	2025-02-14
2024-09-30	$913,044	15,868	-27.5%	Shares	Defined	2024-11-14
2024-06-30	$905,039	21,882	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.